{"id":136967,"date":"2022-11-18T09:18:32","date_gmt":"2022-11-18T14:18:32","guid":{"rendered":"https:\/\/44.250.171.167\/?p=136967"},"modified":"2022-11-18T09:21:44","modified_gmt":"2022-11-18T14:21:44","slug":"infographic-brooks-labrotories-nse-brooks-q4fy22-results-released-revenue-up-94-55-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q4fy22-results-released-revenue-up-94-55-yoy\/","title":{"rendered":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q4FY22 Results Released! | Revenue UP 94.55% YoY"},"content":{"rendered":"\n

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards.<\/p>\n\n\n\n

The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range of products for the critical care segment in the parenteral section such as Beta Lactam Cephalosporin and generic dry powder injection ampoules and liquid vials Dry syrups and tablets etc.<\/p>\n\n\n\n

Their product portfolio currently includes 28 injectables 19 tablets and 2 dry syrups that are sold on the domestic market. The company’s manufacturing facilities are designed to manufacture various products in the formula segment using a combination of processes. V Baddi manufactures a wide range of products in the formulation segment for various top companies in India.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

The company’s total revenue on a consolidated basis for the quater ended March 31, 2022 stood at Rs 28.6 Crore, an increase of 94.55 % over the previous year. The company’s operating expenses on a consolidated basis for the quater ended March 31, 2022 stood at Rs 32.4 Crore, an increase of 75.13 % over the Previous Year. <\/p>\n\n\n\n

Loss before tax is Rs 6.5 Crore, an increase of 79.19 % over the previous year. EPS on a consolidated basis for the quater ended March 31, 2022 stood at Rs 1.5, an increase of 11.53 % over the Previous Year.<\/p>\n","protected":false},"excerpt":{"rendered":"

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range of products for the critical […]<\/p>\n","protected":false},"author":1932,"featured_media":134522,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1941,5747,5,6350],"tags":[1408,1115],"class_list":["post-136967","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock-analysis","category-healthcare-stocks","category-latest","category-trending-stocks","tag-pharma-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":136955,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q2-results-released-revenue-down-15-74-yoy\/","url_meta":{"origin":136967,"position":0},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q2 Results Released! | Revenue DOWN 15.74% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":136962,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q1-results-released-revenue-down-23-21-yoy\/","url_meta":{"origin":136967,"position":1},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q1 Results Released! | Revenue DOWN 23.21% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":143944,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-revolutionizes-healthcare-industry-with-groundbreaking-research-and-innovation\/","url_meta":{"origin":136967,"position":2},"title":"Brooks Laboratories Ltd. Revolutionizes Healthcare Industry with Groundbreaking Research and Innovation!","author":"Divyansh_Kasana","date":"April 21, 2023","format":false,"excerpt":"Stock Data: TickerNSE: BROOKS & BSE:\u00a0533543ExchangeNSE & BSEIndustryPHARMACEUTICALS & BIOTECHNOLOGY Price Performance: Last 5 Days-1.49%YTD-39.27%Last 12 Months-33.95% Company Description: Brooks Laboratories Ltd is a contract-based pharmaceutical manufacturing company with a diversified product portfolio that includes dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions used in\u2026","rel":"","context":"In "Research Summary"","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":136984,"url":"https:\/\/alphastreet.com\/india\/everything-you-need-to-know-about-brooks-laboratories-limitednsebrooks-stock-up-30-in-2-months\/","url_meta":{"origin":136967,"position":3},"title":"Everything You Need to Know About Brooks Laboratories Limited(NSE:BROOKS)| Stock UP 30% in 2 Months","author":"Divyansh_Kasana","date":"November 20, 2022","format":false,"excerpt":"Brooks Laboratories Limited(NSE:BROOKS) has an industry presence of nearly two decades now, leading to established relationships with the customers as well as suppliers. The company is engaged in the manufacturing of pharmaceutical formulations and is supplying to various reputed players.\u00a0 Brooks Laboratories Limited(NSE:BROOKS) has floated a Joint Venture (JV) named\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":141613,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-nse-brooks-ltd-q3-fy23-results-out-total-income-fell-20-yoy\/","url_meta":{"origin":136967,"position":4},"title":"Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY","author":"Divyansh_Kasana","date":"February 14, 2023","format":false,"excerpt":"Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets.\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":153640,"url":"https:\/\/alphastreet.com\/india\/sakar-healthcare-ltd-q1fy24-1-fall-in-profits\/","url_meta":{"origin":136967,"position":5},"title":"Sakar Healthcare Ltd Q1FY24; 1% fall in Profits","author":"Chirag Gupta","date":"August 14, 2023","format":false,"excerpt":"Sakar Healthcare Ltd is engaged in manufacturing of Pharmaceutical formulations in the form of liquid injectables, tablets\/ capsules, oral liquid syrups, dry powder injectables and syrups. The company also operates as a contract development and manufacturing organization (CDMO) for various leading pharmaceutical companies. Financial Results: Sakar Healthcare Ltd reported Revenues\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/136967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=136967"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/136967\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/134522"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=136967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=136967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=136967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}